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Abstract
As healthcare in the United States transforms, the voice of advocacy for pediatric patients is also
evolving. The act of inserting a peripheral intravenous (IV) catheter for medical care of a
pediatric patient is one of the most common invasive procedures in the healthcare industry.
However, the preventable pain accompanying such a common procedure is often overlooked.
Pediatric patients are different than adults due to the lack of physiological and psychological
development. When a peripheral intravenous catheter is inserted without pain prevention
interventions, there are long-term and short-term consequences for the patient and family. In
turn, there are many benefits attributed to utilizing pain prevention interventions during IV
insertions. For this project, the standardization of topical analgesics for pain prevention
interventions is the main focus for decreasing pediatric pain during IV insertion. For this
evidence-based project, the purpose is to implement and standardize the use of topical analgesics
for pain prevention interventions during peripheral IV insertions for pediatric patients. The aim
of this project is as follows: By December 1, 2022, at least 85% of pediatric patients admitted on
the inpatient surgical unit at East Tennessee Children’s Hospital, requiring peripheral
intravenous access, will receive topical analgesics as a form of pain prevention interventions.
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Decreasing Pain in Pediatric Patients During Intravenous Catheter Insertions in
Emergency Departments
I. INTRODUCTION
Focusing on decreasing pain and anxiety in pediatric patients during intravenous (IV)
catheter insertions, not only at local pediatric hospitals but also within surrounding adult
hospitals, is imperative to advancing patient and family centered care during the inpatient
hospital experience. This unique population of pediatric patients can become easily overlooked
during the busyness of a pediatric inpatient surgical unit. Utilizing proper topical analgesia to
potential IV sites represents the focus of interventions for decreasing pain during IV insertions.
Proper topical analgesics include Eutectic Mixture of Local Anesthetics (EMLA) composed of
2.5% lidocaine and 2.5% prilocaine, Lidocaine 4% (LMX) and vapocoolant spray, such as
Painease Spray.
In the pediatric realm of healthcare, the focus is on the overall care of the patient and
patient experience. However, there is also a unique aspect to healthcare regarding pediatrics.
The focus shifts from patient centered care to patient and family centered care. Potts et al.
(2012) stated, “Timely administration of analgesia affects the entire emergency medical
experience and can have a lasting effect on a child’s and family’s reaction to current and future
medical care” (p. e1391). Recognizing that pediatrics is a specific population within a
community creates room for growth in this particular realm of healthcare. Understanding the
foundation of pediatric pain in healthcare can begin on the pediatric inpatient surgical unit by
considering how painful procedures, such as IV insertions, are handled by nursing staff. This
component is vital to the progression of pediatric healthcare as a whole. Kennedy et al. (2008)
emphasized, “Studies also suggest a correlation between childhood pain and fear associated with
medical procedures and adult pain sensitivity, fear, and avoidance of health care” (p. S131).
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These seemingly small interventions are often overlooked or disregarded, which increases levels
of preventable pain in pediatric patients during inpatient visits.
Significance of the Problem
Pediatrics is a specific population. Simple procedures, such as IV insertions, can cause
major stress, anxiety, and pain for the patient and the caregiver (Potts et al., 2012).
Standardization of care regarding pain prevention during IV insertions in the pediatric population
needs to be addressed in healthcare. Pediatrics is a distinct population due to the fact that this
population is still developing mentally, emotionally, and physically. Studies are starting to
surface and reveal the long-term effects of painful procedures that were not controlled. As
mentioned by Kennedy et al. (2008) painful procedures from toddlerhood can affect a patient’s
long-term outlook on healthcare and lead to avoidance of routine health hygiene. Kennedy et al.
(2008) also highlighted that preterm and term infants develop their pain pathways pre and
postnatally, which could lead to more intense pain experiences than older children. Duerden et
al. (2018) continued on this topic by stating, “Early exposure to repetitive procedural pain in
very preterm neonates may disrupt the development of regions in somatosensory processing,
leading to poor functional outcomes” (p. 878).
Ten years ago, there were nearly 1.25 million pediatric inpatient surgical cases
nationwide ranging from bone fracture repairs to scheduled tonsillectomy procedure. These
cases reflect children from 1-17 years of age (Witt et al., 2014). Transitioning from a national
scale to a more local scale, the number of inpatient admissions at East Tennessee Children’s
Hospital totaled 3,846. According to ETCH’s Annual Report (2020), for the 2019-2020 year,
569 of 3,846 admissions were on the inpatient surgery unit. Unfortunately, pain prevention
interventions (PPI) were not included in the Annual Report for ETCH due to lack of audits.
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However, the Pain and Palliative Care Team (PPCT) at ETCH has started focusing more
on auditing PPI utilization during IV insertions and IV attempts, partially due to patient and
family satisfaction scores dropping and comments regarding the lack of pain control for IV
insertions. The PPCT has recently started working with the informatics team at ETCH to
develop a way to audit and keep track of the total number of IV insertions and attempts based on
charting by nursing staff on each unit. January 2021 was the first official month of tracking
these numbers. The figures provided by this new tracking system exhibited nearly 75% of IV
attempts in January did not incorporate PPIs. Per the Palliative Care Coordinator and member of
the PPCT, with this new way of tracking IV insertions at ETCH, there are many aspects involved
(personal communication, January 2021). The following items are included:
•

Name and credentials of nurse inserting the IV

•

Type of analgesia and/or pain prevention intervention utilized

•

Whether the IV attempt was successful or unsuccessful

•

Medical record number of the patient

•

Date and time of insertion

All these sources of internal evidence are relevant. One more piece of information that would be
valuable in tracking PPIs would be a pain assessment utilizing the Likert Scale. This scale
would include how well the patient tolerated the IV insertion from the nurse’s perception. The
three tolerance observation options would include good, fair, or poor.
There are many distinctive aspects regarding the pediatric population receiving IVs in the
community and nationally. Understanding the research regarding the benefits of topical
analgesia is crucial for progressing evidence-based healthcare for these patients and their
families. Access to adequate healthcare which provides sufficient pain control during IV
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insertions for pediatric patients is not easily found or tracked. Regulating pain control through
the standardization of PPIs is extremely important and can create medical experiences for these
children that are easier and less painful. Creating a positive experience can lead to better health
hygiene as these patients move into adulthood. However, there are always exceptions. The
exception to utilizing topical pain prevention and/or distraction would be if an IV was needed
emergently. For instance, if a patient was experiencing a prolonged seizure or if a patient went
into cardiac arrest, an IV would need to be inserted immediately. Emergent IV insertions are not
included in the data set previously mentioned.
Purpose and Goals
Currently, there is no standardization of care regarding pain prevention during IV
insertions in the pediatric population at ETCH. This specific standardization is desired by ETCH
due to declining patient satisfaction scores and comments specifically regarding pain during IV
insertions on the pediatric IPS unit. The purpose of this project is to standardize pain prevention
with the use of topical analgesics during IV insertions. The goals of this project consist of the
following:
•

Decrease preventable pain during IV insertions in the pediatric population by
utilizing topical analgesics

•

Increase the focus on patient and family centered care

•

Increase overall patient satisfaction scores

By December 1, 2022, at least 85% of pediatric patients requiring peripheral intravenous access
will receive pain prevention interventions in the form of topical analgesia on the pediatric
inpatient surgery unit at East Tennessee Children’s Hospital.
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PICO Development and Statement
Cultivating a precise question which focuses on a desired change in a clinical setting is
the first priority in generating change. Considering this PICO question, the patient/population
(P) is the pediatric population. The (I) is the use of topical pain prevention interventions, as
compared (C) to current practice and will result in a decreased in pain levels (O). The PICO
question for this proposed project is, “In pediatric patients, does the use of pain prevention
interventions, compared to current practice, decrease pain levels during intravenous catheter
insertions on the pediatric inpatient surgery unit?”
Evidence-Based Practice Model Guiding Project
The Johns Hopkins Nursing Evidence-Based Practice Model (JHNEBP) will guide this
project. The JHNEBP Model consists of three separate phases. These phases consist of practice
question, evidence, and translation. These phases are also known as PET. The first phase is
focused on the Practice question. The second phase is dedicated to Evidence, while the third
phase is fixated on Translation of evidence into changes in practice. There are a total of 19 steps
in the JHNEBP PET process. Breaking down the process of standardizing the use of PPIs to
decrease pain in pediatric patients during IV insertions on the pediatric IPS unit is achievable
with this specific model. The JHNEBP Model is centered around an open system which has
interconnected factors. The JHNEBP Model also allows for external and internal factors to
influence its open system (Dang & Dearholt, 2018).
Dang and Dearholt (2018) breakdown each of the following phases followed by each step
for clarity. Steps 1-6 of the JHNEBP PET Process focused on developing a practice question
and an EBP question that is answerable. The first six steps include the following:
•

Recruit interprofessional team
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Define the problem

•

Develop and refine the EBP Question

•

Identify stakeholders

•

Determine responsibility for project leadership
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The development of the PICO question for this proposed project was achieved by identifying a
clinical practice problem. The lack of standardization at ETCH in regards to pain prevention
during IV insertion on the pediatric IPS unit is the identified clinical practice problem.
Interprofessional team members have met to help refine the question to the highest potential and
simplest form.
The second phase consists of steps 7-11. These steps focus on examining, evaluating,
and synthesizing the evidence that is available regarding the chosen clinical practice problem.
The second set of steps are essential in the discovery of sound evidence, as well as developing
recommendations for change. Steps 7-11 include the following:
•

Conduct internal and external search for evidence

•

Appraise the level and quality of each piece of evidence

•

Summarize the individual evidence

•

Synthesize overall strength and quality of evidence

•

Develop strong recommendations for change based on evidence synthesis

The last phase of the JHNEBP Model consists of steps 12-19. These steps include:
•

Determine fit, feasibility, and appropriateness of recommendations for translation path

•

Create action plan

•

Secure support and resources to implement action plan

•

Implement action plan
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Evaluate outcomes

•

Report outcomes to stakeholders

•

Identify next steps

•

Disseminate findings
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II. EVIDENCE
Literature Search Strategy
To answer the PICO question mentioned above, a literature search was started. Initially,
three databases were utilized: CINAHL; PubMed; and Cochrane. Selecting key words for
possible search terms was vital to yielding relevant search results. For the PICO question, the
search terms included “pain”, “intravenous catheter”, “venipuncture”, “pediatric”, “inpatient”,
“vapocoolant”, “topical analgesic”, “EMLA”, “LMX”, and “pain prevention”. As the searches
progressed with the three referenced databases, these terms evolved and adapted. With regard to
the search strategy, the search terms were combined with the Boolean terms (AND and OR) to
obtain a generalized search of the topic.
The first database utilized was CINAHL. For the first search, the key words used were
“pain” AND “pediatric” AND “intravenous”. This search did not have any filters or limits
applied and it yielded 597 initial results. A filter was added to yield results between 2016 and
2021. This filter yielded 113 results. Five abstracts were reviewed and four were kept for
possible future use. The second CINAHL search consisted of the key terms “pediatric pain”
AND “intravenous” AND “inpatient”. This search had a filter limiting results to the past 10
years. It yielded 33 results and four were reviewed while keeping two of the articles. The third
CINAHL search was similar. No filters or limits were applied and the key terms used were
“pediatric pain” AND “intravenous” AND “vapocoolant”. This search generated three results.
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One abstract was reviewed and one article kept from this specific search. The last search via
CINAHL used the key terms “pediatric pain” AND “intravenous” AND “EMLA”. As with the
other three CINAHL searches, there were no filters or limits applied and there were 23 results.
Two of these articles were reviewed and both were kept for future use.
The second database utilized was PubMed. For the PubMed searches, no limits or filters
were applied. The key terms for the first search were “pain prevention” AND “intravenous
catheter” AND “inpatient”. This search yielded 13 results, while two were reviewed only one
was kept. The second PubMed search consisted of the terms “pain prevention” AND
“intravenous”. A filter was applied to yield results from 2016 to 2021. This search generated 82
results. Three of the results were reviewed and one was kept for possible future use. The third
PubMed search consisted of the key search terms “intravenous” AND “pediatric” AND
“inpatient”. This search produced 359 results. Ten of these results were reviewed and one was
kept.
Lastly, the third database applied was Cochrane. Two searches were conducted with this
database. As with PubMed and CINAHL, there were no filters or limits applied for the searches.
The first search consisted of the terms “pediatric pain EMLA” and yielded 34 results. Five of
these 34 results were reviewed and zero were kept. The last search through Cochrane used the
terms “intravenous catheter pediatric pain”. With this search, there were only two results. One
of these results was reviewed and one was kept. Listed below is Figure 1 exhibiting the
PRISMA Flow Diagram to the extent of completion that the search narrative allowed.
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Figure 1

Identification

Adapted PRISMA Flow Diagram

Records identified through
database searching
(n = 657 )

Additional records identified
through other sources
(n = 0)

Eligibility

Screening

Records after duplicates removed
(n = 418)

Records screened
(n = 33)

Records excluded
(n = 17)

Full-text articles assessed
for eligibility
(n = 11)

Full-text articles excluded,
with reasons
(n = 21)

Included

Studies included for
critical appraisal
(n = 5)

Studies included in
synthesis of literature
(n = 5)

From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses:
The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097
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Critical Appraisal of the Literature
The guidelines and multiple tools utilized for conducting critical appraisals of literature
were from The Johns Hopkins Nursing Evidence Based Practice (JHNEBP) guidelines. The
JHNEBP Appendix E: Research Evidence Appraisal Tool was one specific tool for guiding these
appraisals of literature (see appendix A). This specific appraisal tool helped to identify whether
the literature was quantitative, qualitative, or mixed methods. Throughout the tool, the evidence
level and quality rating were obtained (Dang & Dearholt, 2018). There were five separate
articles that were critically appraised in relevance to the desired PICO question. Table 1
illustrates the critical appraisal of each article.
Synthesis of Evidence
Pain during IV insertion in pediatric patients is an extremely preventable source of pain.
The literature and research reviewed have proven true revealing there are many different topical
analgesics to prevent pain during IV insertion. Pain scores in each research setting proved to
decrease with a statistical significance. Of the five articles, all sample sizes were adequate and
all were quality grade A. The evidence of each article revealed PPIs, ranging from J-Tip
needless devices delivering 1% lidocaine in the desired IV placement area to the use of
vapocoolant spray to aid in the decrease of pain levels during insertion. Table 2 reveals the
synthesis of evidence for each article appraised.
Clinical Expertise Evidence
The thought of pain prevention during IV insertions for pediatric patients is not new.
However, the clinical expertise backing and the evidence-based practice that is starting to
support this concept is one step closer to standardizing PPIs for all IV insertions in the pediatric
patient population. An increase in evidence has shown venipuncture as a major source
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Table 1
Literature Evaluation
Article Citation

Conceptual
Framework
and Purpose

Design/Method

Sample/Setting

Major
Variables
Studied (and
Their
Definitions)

Measurement

Data
Analysis

Findings

Appraisal: Worth to
Practice

Singer, A. J.,
Taira, B. R.,
Chisena, E. N.,
Gupta, N., &
Chipley, J.
(2008). Warm
lidocaine/tetracai
ne patch versus
placebo before
pediatric
intravenous
cannulation: A
randomized
controlled
trial. Annals of
Emergency
Medicine,52(1),
41-47.
doi:10.1016/j.an
nemergmed.2008
.01.336

No conceptual
framework

RCT double-blind

N = 40

Random
assignment of
lidocaine/tetracain
e versus placebo
patch via
computerized
random-numbers
table, placed on
patients in triage
potentially
requiring an IV

n = 20 patients w/
lidocaine/
tetracaine patch

IV: lidocaine/
tetracaine patch
placed on
potential IV site
in triage
IV2: placebo
patch

The Visual
Analog Scale
(VAS) and the
Wong Baker
Faces Scale
(WBFC) were
both used as
measurements
for selfreporting pain
post
intravenous
catheter
insertion

Continuous
nonparametric
data (median
and
interquartile
ranges)
compared with
a MannWhitney U test

Median
pain: 18
mm w/
IQR 1-40
mm
compared
to placebo
median of
35 mm w/
IQR 20-59
mm

Strengths: random
placement of
impregnated patch
versus placebo by triage
nurse; the same gauge
catheter attempted to be
used on each patient

Level - I
Quality Grade-A
High Quality

Setting:
suburban,
academic,
university-based
ED

Purpose: to
compare the
pain of
intravenous
cannulation in
pediatric
emergency
department
patients after
applying a
topical
lidocaine/tetra
caine patch
versus a
placebo.

n = 20 patients w/
placebo patch
Age b/w 3-17 yo
Attrition: none
noted

DV: selfreported pain
levels after
insertion

Parametric
data (means
and standard
deviations)
compared with
a t test

Mean pain:
(SD) 9.3
(4.3) vs
placebo
mean (SD)
of 10.8
(4.5).

Note. DV = dependent variable, IV = independent variable, RCT = randomized controlled trial, IQR = interquartile range, SD = standard deviation

Limitations: small
sample size,
combination of ordinal
and nominal data,
children ages 3 and
under not included, no
control group that did
not receive a patch
There is no risk or harm
if
study intervention would
be implemented into
practice; feasible in
practice as long as there
would be 20 minutes
before IV insertion
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Table 1
Article Citation

Conceptual
Framework
and Purpose

Design/Method

Sample/Setting

Major
Variables
Studied (and
Their
Definitions)

Measurement

Data
Analysis

Findings

Appraisal:
Worth to
Practice

Kelly, S.,
Russell, J.,
Devgon, P., &
Rosen, P. (2017).
Transformation
of the peripheral
intravenous
catheter
placement
experience in
pediatrics. The
Journal of
Vascular
Access,18(3),
259-263.
doi:10.5301/jva.
5000652

No
conceptual
framework

Non-randomized cohort
case-control study

N = 85

IV: lidocaine
infused J-Tip
administratio
n

The Wong
Baker Faces
Pain Rating
Scale (WBFC)
was used as the
survey
instrument to
measure pain
levels after
intravenous
cannulation

Continuous
data with an
independent
sample t-test
for age and a
Pearson Chisquare for
gender to
ensure
homogeneity
of groups

Mean pain
score of
patients that
received
subcutaneous
lidocaine
was 2.45

Strengths:
adequate
sample size,
patients were
able to selfreport pain via
survey
instrument

Purpose: to
compare the
pain of
intravenous
catheter
insertion with
and without
lidocaine
administratio
n via the JTip needlefree injection
system

Enrollment of patients
from the ED and
inpatient areas that were
able to utilize the WongBaker Faces Pain Rating
Scale for lidocaine
infused J-Tip devices
and no intervention prior
to intravenous
cannulation

n = 41 patients received
needle-free injected
lidocaine pretreatment
prior to intravenous
cannulation
n = 44 patients received
zero pain prevention
interventions prior to
intravenous cannulation
Age b/w 3-16 yo

Level – II
Quality Grade – A
High Quality

Attrition: none noted
Setting: academic
pediatric hospital

Note. ED = emergency department, IV = independent variable, DV = dependent variable

DV: selfreported pain
levels after
insertion of
intravenous
catheter

Assessing
group
differences
in pain
required a
two-tailed
independent
sample t-test

Mean pain
score of
patients that
did not
receive
subcutaneous
lidocaine
was 5.83

Limitations:
was not
randomized
which allowed
a possible
selection bias,
variation in
catheter sizes
and bevel
shapes

DECREASING PREVENTABLE PAIN IN PEDIATRIC PATIENTS

20

Table 1
Article Citation

Stoltz, P., &
Manworren, R.
C. (2017).
Comparison of
children's
venipuncture
fear and pain:
Randomized
controlled trial of
EMLA® and JTip needleless
injection
system®. Journa
l of Pediatric
Nursing,37, 9196.
doi:10.1016/j.pe
dn.2017.08.025

Conceptual
Framework
and
Purpose
No conceptual
framework
Purpose:
compare selfreported pain and
fear related to
intravenous
cannulation with
EMLA cream or
1% lidocaine via
J-Tip Needleless
Injection System

Design/Method

Sample/Setting

Major
Variables
Studied (and
Their
Definitions)

Measurement

Data
Analysis

Findings

Appraisal:
Worth to
Practice

RCT

N = 150

Random
assignment to the
group of 75
patients receiving
EMLA cream or
the group of 75
patients receiving
subcutaneous
lidocaine via the JTip needleless
device were
assigned via
drawing sealed
envelopes with the
specific assigned
group

n = 75 patients with
EMLA cream
application prior to
intravenous
cannulation

IV: EMLA
cream
IV2: lidocaine
via J-Tip
device

Self-reporting
of pain used the
Visual Analog
Scale (VAS) for
a scale of 0-10
with 0
representing no
pain and 10
representing
severe pain

Independent
sample t-tests
examined
equivalence of
the two groups

Mean pain
with
EMLA =
1.63 ±
1.659

Strengths:
randomized
controlled trial,
sufficient sample
size to achieve
significance

Independent
sample t-tests
compared
mean pain
scores reported
with the VAS

Mean pain
with J-Tip
device =
2.99 ±
2.586

Level – II
Quality Grade – A
High Quality

n = 75 patients with
subcutaneous
lidocaine via J-Tip
device prior to
intravenous
cannulation

DV: selfreported pain
and fear levels
after
intravenous
catheter
insertion

Attrition: none noted
Setting: perianesthesia care unit at
Connecticut
Children’s Medical
Center form
November 2012 to
February 2013

Note. IV = independent variable, IV2 = second independent variable, DV = dependent variable

Fear level was
self-reported
with the
Children’s Fear
Scale (CFS)
which utilized
five different
faces on a
horizontal scale
with different
fear expressions

Analysis of
variance for
repeated
measures
compared the
self-reported
procedural fear
scores

Children
who
received
EMLA
reported
less pain

Limitations:
single site
recruitment of
patients, catheter
placement site
and size were not
standardized,
other nonpharmacologic
methods of pain
prevention were
not documented if
used
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Table 1
Article Citation

Conceptual
Framework
and Purpose

Design/Met
hod

Sample/Setting

Major Variables
Studied (and
Their
Definitions)

Measurement

Data
Analysis

Findings

Appraisal:
Worth to
Practice

Lunoe, M. M.,
Drendel, A. L.,
Levas, M. N.,
Weisman, S. J.,
Dasgupta, M.,
Hoffmann, R. G.,
& Brousseau, D. C.
(2015). A
randomized
clinical trial of jetinjected lidocaine
to reduce
venipuncture pain
for young
children. Annals of
Emergency
Medicine,66(5),
466-474.
doi:10.1016/j.anne
mergmed.2015.04.
003

No conceptual
framework

Randomized
single-dose
clinical trial

N = 205

IV: 1% lidocaine
injection via J-Tip
and spray of
normal saline

The FLACC
scale was
utilized by
physicians
scoring pain of
patients
receiving the
intravenous
catheters. The
physicians
were blinded
to each
intervention

Group
characteristic
s were
compared
using the
X2/Fisher’s
exact test

Mean change
from baseline
to
venipuncture
for
intervention
group = 0.26;
95% CI

Strengths:
randomized
clinical trial;
large enough
sample size
to maintain
alpha at 0.05

Purpose:
Comparing
pain in
pediatric
patients
receiving an
intravenous
catheter with
lidocaine via JTip device
versus
vapocoolant
spray

Patients and
their
experiences
were recorded
with each
intervention
and pain was
scored by
blinded
physicians
using the
Face, Legs,
Activity, Cry,
and
Consolability
(FLACC)
scale

n = 96 patients in the
intervention group which
received 1% lidocaine via the
J-Tip device and a spray of
normal saline prior to
intravenous cannulation
n = 53 patients in the control
group which received only
vapocoolant spray prior to
intravenous insertion
n = 56 patients in the sham
group which received a
lidocaine free J-Tip injection
and vapocoolant spray

IV3: lidocaine
free J-Tip
injection with
vapocoolant spray
application
DV: Observed
pain by physician
blinded to
interventions with
FLACC scale

The
continuous
and ordinal
context was
compared
using the
KruskalWallis test
along with
the MannWhitney Test

Age b/w 1-6 yo
Attrition: none noted

Level – I
Quality Grade
–A
High Quality

IV2: vapocoolant
spray application

Setting: outpatient laboratory
at a tertiary care children’s
hospital from July 1, 2013
through August, 8 2013

Comparison
of pain scores
were made
utilizing the
Generalized
Estimating
Equation
(GEE)

Mean change
for control
group = 2.82,
95% CI
Mean change
for sham
group = 1.68,
95% CI
Pain scores
were less in
the
intervention
group
compared to
the control or
sham groups

Note. IV = independent variable, IV2 = Second independent variable, IV3 = Third independent variable, DV = dependent variable, CI = confidence interval

Limitations:
not able to
use selfreported data
due to patient
ages, patient
anxiety not
included in
this study, a
plain control
group with no
treatment was
not utilized
due to ethical
concerns
about
withholding
usual care
(vapocoolant
was utilized
as the control
in this study)
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Table 1
Article Citation

Conceptual
Framework
and Purpose

Design/Method

Sample/Setting

Waterhouse, M. R., Liu, D. R., &
Wang, V. J. (2013). Cryotherapeutic
topical analgesics for pediatric
intravenous catheter placement: Ice
versus vapocoolant spray. Pediatric
Emergency Care,29(1), 8-12.
doi:10.1097/pec.0b013e31827b214b

No conceptual
framework

RCT

N = 95

Random
assignment of
ice application
or vapocoolant
spray prior to
intravenous
catheter
insertion

n = 50 patients
were randomly
assigned to
receive ice as a
topical analgesic
prior to
intravenous
catheter
insertion

Purpose: to
compare the
efficacy of two
popular
cryotherapeutic
treatments for
pain control
prior to
intravenous
catheter
insertion

Level – I
Quality Grade –
A
High Quality

n = 45 patients
received the
vapocoolant
spray, Painease,
as the topical
analgesic
Age b/w 9-18 yo
Attrition: none
noted

Major
Variables
Studied
(and
Their
Definitions)

Measurement

Data
Analysis

Findings

Appraisal:
Worth to
Practice

IV: ice
application

Patients selfreported pain
via the VAS
during three
separate time
periods
(baseline, pretreatment,
catheter
insertion); the
PI and two
physicians
also measured
the patients’
observed pain
scores via the
VAS

Median
VAS
scores
compared
with the
Wilcoxon
Rank
Sum test

Average
patient VAS
regarding
pain during
intravenous
catheter
placement
with
Painease = 9

Strengths:
Sufficient
sample size,
randomized
controlled
trial, VAS
self-reported
and observed

IV2:
vapocoolant
spray
DV: VAS as
self-reported
and observed
VAS score
given by PI
and two
physicians

Average
patient VAS
regarding
pain during
intravenous
catheter
placement
with ice
application =
13

Limitations:
It can be
difficult for
children to
differentiate
between fear,
anxiety, and
physical pain
in some
cases. Use of
distraction
methods not
documented
or accounted
for

Setting:
pediatric ED
Note. PI = principal investigator, RCT = randomized controlled trial, ED = emergency department, VAS = visual analog scale, DV = dependent variable, IV = independent
variable, IV2 = second independent variable
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Table 2
Synthesis of Evidence
Outcome

Singer et al.,

Kelly et al.,

Stoltz & Manworren

Lunoe et al.,

Waterhouse et al.,

(2008)

(2017)

(2017)

(2015)

(2013)

Pain scores1

s

s

s

s

s

Fear scores2





c





Sample Size

45 patients

85 patients

150 patients

205 patients

95 patients

Level of
Evidence

I

II

II

I

II

Quality of
Evidence

A

A

A

A

A

Note. =decrease; =increase; =not discussed in study; s=statistical significance; c=clinical significance; 1= primary outcome; 2= secondary outcome
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of pain that is long lasting. Nonetheless, there are multiple PPIs (pharmacologic and
nonpharmacologic) that are gaining traction in the evidence-based practice realm of healthcare
(Kennedy et al., 2008). These PPIs are hard to ignore, especially when patients and their family
members start asking for them before any type of venipuncture procedure.
Patient and Family Preferences and Values
Understanding how a patient’s preferences and values, as well as their family’s
preferences and values, impact pediatric healthcare is crucial for this specific DNP project.
Since this project focuses on pain prevention interventions for pediatric patients prior to IV
catheter insertion on the pediatric IPS unit, involving family is a pivotal point in providing
proper care for the patient. Shave et al. (2018) reviewed the common belief that parents have an
innate ability to perceive their child’s body language during anxious situations. Understanding
and supporting a parent or caregiver’s level of knowledge and preferences before initiating a
procedure, such as inserting an IV, can be utilized as a source of nonresearch evidence in this
specific project. Dall’Oglio et al. (2018) consider a family centered care (FCC) approach as an
approach in which all family members are considered care recipients and have the potential to
“benefit from information sharing, participation, and collaboration in the care given” (e18).
With regards to using a patient-centered approach during development, implementation,
and evaluation of this DNP project, a specific approach is going to include gathering patient and
family feedback via patient satisfaction surveys (PSS) at ETCH. Though the patient satisfaction
survey is the same hospital wide, patients and families that were assessed on the pediatric IPS
unit and had IV placement, answer survey questions on that portion exclusively. Gathering data
based on patient and family responses to the PSS can help guide and create evidence for this
specific DNP project.
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Recommendations for Practice
Once multiple critical appraisals were reviewed and evidence gathered regarding a topic
of practice change, it was crucial to understand and portray the strength of such a
recommendation. Regarding PPIs prior to IV insertion in pediatric patients, there is strong
evidence to support the validity and need for standardization of such interventions. Though there
are multiple topical analgesics for pain prevention prior to IV insertions, each intervention is
deemed effective over current practice of no intervention utilized. However, some interventions
are more effective than others, as proven in the research reviewed. Tables 3 and 4 express the
recommendation and the strength of such recommendation regarding PPIs and IV insertions on
pediatric patients.
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Table 3
Recommendation for Practice Change
Recommendation

1. It is recommended
to implement
standardized pain
prevention
interventions prior
to intravenous
catheter insertions
for pediatric
patients on the
pediatric IPS unit.

References in
Support of
Recommendation

Rationale

Level of
Evidence
(JHNEBP
Tool)
I

Quality
Rating
(JHNEBP
Tool)
A

Singer et al.,
(2008)

The authors found adequate pain relief was more
common in the group of pediatric patients having
the lidocaine/tetracaine patch placed before
intravenous (IV) catheter insertion. There was
statistically significant data in regards to pain rating
via the visual analog scale between the
lidocaine/tetracaine group and the placebo group
upon IV insertion.

Stoltz &
Manworren
(2017)

EMLA application, versus an injection of lidocaine
via J-Tip device, prior to IV insertion was found to
be superior for pain prevention based on patients’
self-reported pain during insertion

II

A

Kelly et al.,
(2017)

The authors’ results revealed consistency in using
needle-free injection of lidocaine as an effective
intervention for pain prevention in patients who
require IV insertion. This was compared to a
second group of pediatric patients that had received
lidocaine free injections

II

A
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Lunoe et al.,
(2015)

The subcutaneous injection of 1% lidocaine via the
J-Tip needleless device was found, by the authors
during the randomized clinical trial, to decrease
pain associated with intravenous catheter insertions
in pediatric patients. These results were compared
to a second group of patients that did not receive
any lidocaine prior to intravenous catheter insertion

I

A

Waterhouse et al.,
(2013)

Painease, a vapocoolant spray, was found to be
superior in pain control when compared to ice
application as a topical analgesic prior to
intravenous catheter insertion

I

A

DECREASING PREVENTABLE PAIN IN PEDIATRIC PATIENTS

Recommendation
1. It is recommended to to implement
standardized pain prevention
interventions prior to intravenous
catheter insertions on pediatric
patients on the pediatric IPS unit.
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Strength of Evidence for
Recommendation

References in Support of
Recommendation

Given the level of evidence and quality
ratings found in the JHNEBP, the overall
strength of the evidence provided is
considered “good and consistent
evidence” which suggests “considering a
pilot of change” (Dang & Dearholt, 2018).

Singer et al., (2008)
Stoltz & Manworren (2017)
Kelly et al., (2017)
Lunoe et al., (2015)
Waterhosue et al., (2015)
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III. IMPLEMENTATION
Project Setting and Population
The setting for this DNP project will take place on the pediatric IPS unit of a freestanding pediatric hospital that serves the counties of East Tennessee, as well as counties in
Southeast Kentucky and Southwest Virginia. This free-standing hospital cares for patients
ranging in ages from newborn to 23 years and is one of four certified Comprehensive Regional
Pediatric Center in the state of Tennessee. According to the hospital’s annual report, in 20192020, this IPS unit saw nearly 600 pediatric patients. The unit is staffed by registered nurses
(RNs), medical doctors (MDs), physician assistants (PAs), nurse practitioners (NPs) unit techs,
and a multitude of ancillary staff. Hospital-wide in 2020, there were nearly 7,600 patients and
families assisted by Interpretive Services (IS). The top three languages interpreted were Spanish,
Swahili, and Akateko. The pediatric IPS unit serves a diverse population in the southeast region.
Participants
Specifically, the focus of this project will be on the pediatric patient population on the
IPS unit who require an IV for treatment. The patients to be included will range in ages between
7 – 21 years of age, which will allow the use of the of an age-appropriate pain scale. The project
will utilize the Likert scale. The Likert scale includes the following ratings for pain: good, fair,
or poor. Good represents no pain at all and progresses to poor, which represents the patient did
not tolerate the IV insertion well due to noticeable pain from the inserting nurse. The patients
that will be included in this project will be non-emergent patients arriving to the unit via
scheduled surgery or from an emergency department (ED) admission. Patients that had
previously received an IV in the ED or the operating room have the potential to lose, or
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accidently remove, the IV – which would create a need for a new IV to be inserted. These
patients requiring a new IV would be included for this project.
Barriers and Facilitators
There are multiple barriers involved that need to be recognized and mitigated before
interest and support are acquired. Regarding this DNP project, there are four different categories
of barriers to consider. Understanding which stakeholder is involved with each category is
important for mitigation purposes. Being aware of an organization’s leadership and whether the
infrastructure is suitable for advancing an EBP initiative is priority (Dang & Dearholt, 2018).
Understanding the type of barrier, as well as the stakeholders involved, is essential in moving
forward with a project change. Table 5 illustrates the barriers for implementation for this specific
DNP project, as well as the mitigation approach for each barrier.
Identifying facilitators for this DNP project is just as pertinent as identifying barriers
when aspiring to create a successful and supportive EBP setting (Dang & Dearholt, 2018). The
facilitators for this DNP project are intertwined with the hospital’s organizational culture and
leadership support. For example, pediatric IPS staff understand the culture of the hospital and
the mission of improving the health of children through multiple routes. Some of these routes
include comprehensive care and education. Decreasing pain during IV insertions is a large part
of constructing a culture of comprehensive care. Table 6 illustrates the facilitators for
implementation and the facilitator aids for this project.
Upon assessing an organization for a project change, an analysis of the strengths,
weaknesses, opportunities, and threats (SWOT) is beneficial. A SWOT analysis was conducted
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Table 5
Barriers for Implementation
Category

Attitudes

Knowledge and
Skills

Stakeholder

Description of Barrier

Barrier Mitigation

IPS Nursing Staff

Nursing staff resistance
to change due to staff
possibly perceiving an
increase in patient care
time for PPIs

EBP regarding efficient
time for each PPI
management

IPS Manager and
ANM

Hesitancy to EBP
change due to other
issues, such as staffing,
that needs to be
resolved first

Providing evidence and
resources of the Triple
Aim in healthcare
expressing why EBP
culture is necessary

IPS Manager and
ANM

Unaware of current
EBP regarding topical
PPIs for pediatric IPS
units

Provide evidence-based
resources and current
practice changes
concerning topical PPIs

IPS Nursing Staff

Unaware of what PPIs
are options prior to IV
insertion; unaware of
storage of such PPIs on
the IPS unit

Education and training
(hands on and CBL) on
the types of PPI
available and where
each PPI is located in
the unit

Note. IPS = Inpatient Surgery Unit, ANM = Assistant Nurse Manager, PPI = Pain Prevention Intervention, IV =
Intravenous, EBP = Evidence Based Practice
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Resource: Time

Resource:
Financial

Stakeholder

Description of Barrier

32

Barrier Mitigation

FTAC

Limited meeting times
with limited time slots
allotted to each topic

Utilize other resources
for consultation, such as
surveys or video chats

PPCC

More time demanded
Create a streamlined
for meetings and project
plan for meetings and
attention on top of other
dates ahead of time
daily duties

PPCC

More time demanded
Create a streamlined
for meetings and project
plan for meetings and
attention on top of other
dates ahead of time
daily duties

IPS Manager

ETCH has been in a
financial low due to
COVID-19, which
decreases the amount of
finances available to
extra resources (such as
creating new CBLs for
educating staff)

Incorporate education
during other aspects of
workplace education,
such as having a station
available during the
quarterly ETCH days
mandatory in-person
education

Note. PPCC = Pain and Palliative Care Coordinator, IPS = Inpatient Surgery Unit, CBL = Computer Based
Learning, FTAC = Family and Teen Advisory Council, ETCH = East Tennessee Children’s Hospital
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Table 6
Facilitators for Implementation
Category

Stakeholder

Description of Facilitator

Facilitator Aid

ETCH IPS Staff

The mission of ETCH is to
"Improve the health of
children" through many routes
Utilizing literature to
including comprehensive care
show the benefits of EBP
and education. Decreasing
PPI on the IPS unit
pain during IV insertions is a
large part of creating a culture
of comprehensive care

FTAC

Families and patients are the
By understanding and
foundation of culture at ETCH.
listening to family and
Creating relationships with past
patient thoughts regarding
and present families/patients
PPI, EBP can transform
through FTAC can help give
into standard practice at
insight to PPI needs that might
ETCH
be otherwise overlooked

Data Collection

PPCT

Beginning January 2021, data
collection consisting of PPI
with each IV insertion has
started being tracked based on
nursing charting

Leadership
Support

By creating specific times for Providing education in
education and proper
segments limits the staff
understanding of EBP PPIs for from becoming
IPS Nursing Staff
the IPS staff allows for the staff overwhelmed by new
to have protected time which information on top of
reflects support from leadership daily tasks at work

Organizational
Culture

This creates a new visual
and system of reviewing
how often PPIs are being
utilized on the IPS unit
based on age, gender, and
interventions used during
IV insertion
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Note. PPCT = Pain and Palliative Care Team, ETCH = East Tennessee Children’s Hospital, IPS = Inpatient Surgery
Unit, PPI = Pain Prevention Intervention, IV = Intravenous, EBP = Evidence Based Practice, FTAC = Family and
Teen Advisory

Table 7
SWOT Analysis
Strengths

Already focused on
patient and family
centered care

Weaknesses

Opportunities

Resources are
currently in the process
Quarterly education for staff
of being developed (or
to educate on the "why" of
are newly developed)
pain prevention importance
to keep up with data
related to IV insertions
and pain prevention

Threats

Staff can exhibit the
"this is the way we've
always done it" outlook
on change regarding
simple policies

Mission and vision
statements coincide with
the goals of this project

Data collection is
based solely off
nursing charting

Multiple IV insertions are
ordered on every shift, which
allows for multiple different
learning opportunities
regarding the different types
of topical PPIs

Management team for
the IPS unit supports
gathering data for the
support of this project

No current mandatory
standard of care/policy
regarding pain
prevention with IV
starts

Gaining support from other
IPS Pain Champions
(representatives) from the
PPCT

No one likes change

IV insertions can be
intimidating for newer nurses
- knowing they are doing
everything they can to make
their patient more
comfortable could increase
their confidence levels

The possibility of
support from
management and
multidisciplinary teams
falling through due to
multiple other
projects/changes in the
department

The topical pain PPIs are
all relatively low cost

Quarterly computerbased learning education
helps bridge any gaps of
new knowledge/change
for nursing staff
Note. IPS = Inpatient Surgery Unit, IV = intravenous, PPCT = pain and palliative

Nursing staff not taking
interest in the "why"
behind the proposed
project
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for the IPS unit of the hospital that will be used for this project. Internal aspects of the
organization, such as the strengths and weaknesses, were reviewed. Likewise, external aspects
of the organization, such as opportunities and threats, were analyzed (Teoli et al., 2020). Table 7
exhibits the SWOT analysis conducted for the ED of this hospital.
Project Stakeholders
Stakeholders and their teams assume multiple responsibilities when they agree to
assisting and being a part of a DNP project. For example, there are seven interdisciplinary
stakeholders and teams involved in this project ranging from the DNP student and IPS
management to the Family and Teen Advisory Council (FTAC). For each stakeholder, there is a
list of corresponding responsibilities. Stakeholders are affiliated with a specific agency, and with
this project there are two agencies involved. Table 8 reveals this project’s stakeholders, their
responsibilities, and their affiliated agencies. This team of stakeholders was formed based on the
involvement and ability to share insight of an IV insertion on a pediatric patient. Members from
FTAC could potentially have personal accounts in which the project could benefit from
regarding pain with IV insertion as a patient. On the contrary, IPS management, contributes to
the sustainability aspect of such a possible project change. After discussing what aspects of
stakeholders this project might benefit from with the IPS Nurse Managers, this team was formed.
Implementation Approach
Implementation of the project will utilize the 19-step process of the Johns Hopkins
Nursing Evidence-Based Practice (JHNEBP) Process. This process is comprised of three phases
known as the PET phase involving the Practice Question, Evidence, and Translation (Dang &
Dearholt, 2018). By using this specific implementation approach, the essential steps are broken
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down into detailed phases while the key stakeholders involved with each step are identified. The
essential steps and stakeholders necessary for each step are seen in Table 9. The projected
timeline for this project is also displayed within Table 9. Taking into account ethical
considerations, we sought Internal Review Board (IRB) determination from The University of
Tennessee and the hospital the project will take place in. It was determined by both entities that
this project received an exemption letter for non-human subjects research.
Implementation for this project consists of an educational inforgraph being placed on the
IPS unit. The inforgraph provides information regarding pain prevention interventions and the
benefits of topical analgesics prior to IV insertion. The infograph to be used is shown in Figure
2. Two weeks of baseline data will be collected prior to hanging eight infographs in highly
trafficked nursing areas on the IPS unit. The inforgraph will be left up on the unit for four weeks
and the implementation data will be gathered for those four weeks. Utilizing the EHR, the Likert
scale will be audited for the patients in the applicable age range to this project.
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Table 8

Stakeholders, Responsibilities & Affiliated Agencies
Name/Title

Responsibilities

Affiliated Agency

DNP Student

Project leader, apply EBP,
responsible for collection of
data/analysis and disseminating
results

UTK

Pain and Palliative
Care Coordinator

Leader of PPCT, consult for data
collection strategies and
education related opportunities
for staff related to project

ETCH

IPS Nurse Manager

Leader of project department,
oversee and approve project
procedures/implementation

ETCH

IPS ANM

Assists in approval of changes
and proposed tasks in
department related to PPI

ETCH

DNP Committee
and Statistician

Statistical consulting regarding
PPIs utilized versus current
practice during IV insertions

UTK

IPS Nursing Staff

Consult for input before, during,
and after project change and
implementation

ETCH

FTAC (ages 12-21)

Serves as subject matter experts
regarding PPI from previous
experiences

ETCH

Note. PPCT = Pain and Palliative Care Team, ED = Emergency Department, ANM = Assistant Nurse Manager, PPI
= Pain Prevention Intervention, IV = Intravenous, EBP = Evidence Based Practice, FTAC = Family and Teen
Advisory Council, UTK = University of Tennessee Knoxville, ETCH = East Tennessee Children’s Hospital
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Table 9
Implementation Plan & Project Timeline using the JHNEBP PET Process
Essential Steps
Step 1: Recruit interprofessional team
•

Responsibility of Key Stakeholder(s)

Projected Time Frame

DNP student

January 2021

DNP student

January 2021

Recognize potential interprofessional team members who would
have an interest in the DNP project topic

Step 2: Define the problem
•
•

Lack of standardization regarding PPI during IV insertions on the

Community member

IPS unit in pediatric patients

IPS nursing staff

Accumulate data, quantitative and qualitative, exploring PPI and

IPS nurse manager/ANM

pain levels with IV insertions in pediatric patients on the IPS unit

FTAC

Step 3: Develop and refine the EBP question
•

Question development using the PICO mnemonic

Step 4: Identify stakeholders
•

Identify and determine appropriate key stakeholders to facilitate

DNP student

January 2021

DNP project chair
DNP student

February 2021

Community member

the development of the DNP scholarly project
•

Determine roles of stakeholders based on the person, group, or
department involvement within ETCH

Step 5: Determine responsibility for project leadership

DNP student

•

Establish key leadership members to facilitate responsibilities

DNP project chair

•

Review and evaluate responsibilities for specific stakeholders

Community member

Step 6: Schedule team meetings
•

Community member

Establishing meeting dates for interprofessional teams regarding

DNP student

standardizing PPI with IV insertions for pediatric patients

DNP project chair

March 2021

June 2021
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Responsibility of Key Stakeholder(s)

Plan ahead and schedule future interprofessional meetings

IPS nursing staff

regarding DNP project implementation

IPS nurse manager/ANM

Projected Time Frame

FTAC
Step 7: Conduct internal and external search for evidence
•

DNP student

Engage with librarians to understand, develop, and utilize search

Community member

plans along with specific search terms

UTK librarian

•

Review clinical practice guidelines

•

Conduct literature searches over multiple databases

•

Gather sources of data outside library resources

Step 8: Appraise the level and quality of each piece of evidence

January 2021-September 2021

DNP student

February 2021-August 2021

DNP student

March 2021-June 2021

DNP student

March 2021-June 2021

DNP student

September 2021

Step 12: Determine fit, feasibility, and appropriateness of

DNP student

September 2021

recommendation(s) for translation path

DNP project chair

•

Appraise research and nonresearch evidence, determining level,
type, and quality of evidence with appropriate appraisal tool

Step 9: Summarize the individual evidence
•

Identifies the sums of the evidence and documents the total by
utilizing the Synthesis and Process Recommendations Tool

Step 10: Synthesize overall strength and quality of evidence
•

Determine the strength and overall quality of evidence gathered
focusing on the level, quality, quantity, consistency and
applicability to the DNP project

Step 11: Develop strong recommendations for change based on evidence
synthesis
•

Form a recommendation for practice change based on the overall
appraisal and synthesis of evidence
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Responsibility of Key Stakeholder(s)

Conduct a team meeting including key stakeholders to discuss

Community member

recommendations while addressing relevant questions from the

IPS nursing staff

Synthesis Process and Recommendations Tool

IPS nurse manager/ANM

Assess recommendations to identify any modifications needed

FTAC

Projected Time Frame

PPCC
Step 13: Create action plan
•

DNP student

Develop a standardized process regarding PPI in pediatric patients

DNP project chair

prior to IV insertions while soliciting feedback from IPS nursing

Community member

staff

FTAC

September 2021

IPS nursing staff
Step 14: Secure support and resources to implement action plan
•
•

Maintaining previously obtained approval from ETCH as DNP

DNP project chair

project site for implementation of DNP project

Community member

•

November 2021

Verify stable resources and financial plan

Step 15: Implement action plan
•

DNP student

DNP student

Educate IPS nursing staff with educational flyer via QR code

Community member

access and via email for the IPS department.

PPCC

March 2022

Implement practice change in the IPS to require the
standardization of PPI with IV insertions on pediatric patients on
the IPS unit

Step 16: Evaluate outcomes

DNP student

•

Analyze data findings with statistician

DNP project chair

•

Conduct team meeting to review outcomes

Community member

July-August 2022
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Responsibility of Key Stakeholder(s)

Projected Time Frame

Statistician
Step 17: Report outcomes to stakeholders

DNP student

•

Distribute results of outcomes with key stakeholders

Community member

•

Solicit feedback from key stakeholders related to outcomes

DNP project chair

Step 18: Identify next steps
•
•

DNP student

Analyze and revise next steps based on feedback amongst

DNP project chair

interprofessional team

Community member

October 2022

October 2022

Suggest adjustments as needed

Step 19: Disseminate findings
•

Defend project

•

Present, publish, and disseminate findings

DNP student

November 2022

DNP project chair

Note. PPCC = Pain and Palliative Care Coordinator, CBL = Computer Based Learning, PPI = Pain Prevention Intervention, IPS = Inpatient Surgery Unit, IV = Intravenous, FTAC
= Family and Teen Advisory Council, UTK = University of Tennessee Knoxville, ETCH = East Tennessee Children’s Hospital, DNP=Doctor of Nursing Practice, ANM =
Assistant Nurse Manager
Note. Adapted from “The Revised Johns Hopkins Nursing Evidence-Based Practice (JHNEBP) Model” by D. Dang and S.L. Dearholt, 2018, Johns Hopkins Nursing EvidenceBased Practice: Model and Guidelines, pp. 46-57. Sigma Theta Tau International.
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IV. OUTCOMES AND EVAL
Outcome Measures
For this DNP project, the main outcome measure consists of utilizing the Likert
scale. The specific scale is used for various kinds of ratings and can be used for different
perceptions. This specific use of the Likert scale can be used for patients from a nurse’s
perception of how the patient tolerated the IV insertion. The Likert scale includes the following
ratings for pain: good, fair, poor. Good represents no pain at all and progresses to poor, which
represents the patient did not tolerate the IV insertion well due to immense pain. The outcome
measure for the project will focus on pain scores for IV insertion with and without topical
analgesia pre and post implementation.
To deem the PPI of topical analgesics successful, the data will need to show a decrease in
pain with IV insertions utilizing topical analgesia. The data will be gathered from a six-week
period from patients’ charts ranging from 7-21 years of age. The Likert scale was first utilized in
1932 and has proven to be an effective way to objectively and subjectively measure perceptions,
rate certain systems, and can also be utilized in a questionnaire format (McCleod, 2019). For
this project, a three-point Likert scale will be utilized by the nurse inserting the IV and charted
under the IV insertion intervention. Table 10 displays the essential data points which will be
collected for statistical analysis. All data points will be retrieved from patient charts, pain audits,
or electronic health records (EHR).
Data Collection and Security
Six weeks of data points will be gathered prior to project implementation for baseline
statistics. The baseline statistics will allow for comparison regarding pre and post
implementation of topical PPIs. The data will be gathered via a secure data table created by the
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PPCT at the hospital. The data table gathers the specific data points from patients’ charts and
compiles data for IV insertions based on units in the hospital. The table can be viewed in
intervals of months. The table is secure and it only accessible on hospital property and intranet.
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Table 10
Decreasing Pain in Pediatric Patients During IV Insertions in the ED Evaluation Plan
Variable

Variable

Name

Code

Age

AGE

Variable Description

Data

Possible Range of Values

Source
Age in number of years at

EHR/

time of IPS registration

chart

Level of

Time Frame for Collection

Measurement
#

Ratio

Six weeks

Nominal

Six weeks

Nominal

Six weeks

Nominal

Six weeks

review

Gender

Race

GEN

RACE

Guardian-reported gender of

EHR/

1 = Male

patient at time of IPS

chart

2 = Female

registration

review

3 = Other

Guardian-reported gender of

EHR/

1 = White

patient at time of IPS

chart

2 = Black or African

registration

review

American
3 = Asian/Pacific Islander
4 = Native American or
Native Indian
5 = Other

1 = Hispanic or Latino
Ethnicity

ETH

Guardian-reported ethnicity

EHR/

at time of IPS registration

chart
review

2 = Not Hispanic or Latino

Dichotomous
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Name

Code

Visit Timing

YEAR

Variable Description

Data
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Possible Range of Values

Level of

Source

Time Frame for Collection

Measurement

Year in which IPS visit

EHR/

1 = 2021

Nominal

requiring IV insertion

chart

2 = 2022

Dichotomous

occurred (2021 =

review

Six weeks

preimplementation, 2022 =
postimplementation)

Pain

PPI

Prevention

PPI utilized during IV

EHR/

1 = Yes

Nominal

insertion

chart

2 = No

Dichotomous

Nominal

Six weeks

Nominal

Six weeks

Intervention

Six weeks

review

(PPI)

Type of PPI

Likert Scale

PPIT

LS

Type of PPI utilized during

EHR/

1 = EMLA cream

IV insertion

chart

2 = LMX cream

review

3 = PainEase Spray

Quality Likert score utilizing

EHR/

1 = Good

pain perception from an

chart

2 = Fair

observational standpoint

review

3 = Poor

Note. EHR = Electronic Health Record, PPI = Pain Prevention Intervention, IV = Intravenous, IPS = Inpatient Surgery Unit
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The data retrieved from this secure live table will be entered into a protected data excel sheet and
kept aggregate. The data spreadsheet will be saved in OneDrive for HIPPA/PHI security. There
will be a password to retrieve the spreadsheet. If the data needs to be transferred to the
statistician during consultation, the data spreadsheet will be retrievable via the UT Vault. The
UT vault is a secure and encrypted transfer tool for file sharing. It is also HIPPA/PHI approved.
Data Analysis
Data analysis was conducted with the assistance of Cary Springer, a statistician at the
University of Tennessee, Knoxville. Data was compiled and entered on a spreadsheet for the pre
and post implementation timeframes. Data was analyzed based on the utilization of topical
analgesia as a PPI, and also if PPI was offered but declined by the patient. The newest version of
the Statistical Package for the Social Sciences (SPSS) software application was utilized during
this analysis. A chi-square test will be performed for topical analgesics utilized and for topical
analgesics offered pre and postimplementation. Descriptive statistics will be reported for each of
these tests.
Findings, Significance and Implication
When retrieving data from the pain audit and patient charts, it was discovered the Likert
scale previously referenced no longer existed in the charting system. The tolerance of the
procedure was only documented if the nurse inserting the IV felt the need to add a subjective
comment regarding patient tolerance. This unforeseen aspect changed the way the data was
calculated. Instead of processing a chi-square test on each Likert scale component for pre and
post implementation, the obtainable data was processed regarding whether or not an analgesic
was utilized as a pain prevention intervention with a chi-square test. A second chi-square test
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was also calculated regarding whether or not topical analgesics were offered prior to IV
insertion.
Upon calculating the two chi-square tests, it was found that topical analgesics were
utilized 75% of the time during the two-week baseline period, and 53.3% of the time during the
four-week implementation period. There was no statistical significance found due to the p-value
equaling 0.177. However, it was noted topical analgesics were offered 75% of the time during
the baseline period and 60% of the time during the implementation period. The was also no
statistical significance due to the p-value equaling 0.339.
It is important to note there were seven kids and 12 insertions during the baseline period,
and 26 kids with 50 insertions during the implementation period. There were multiple attempts
that were accounted for, as well, since first attempts were unsuccessful at times. It is also
important to note there were other methods of pain prevention interventions happening at the
same time, with and without topical analgesics. This creates multiple confounding factors in the
data set, which ultimately creates a limitation on this set. Other limitations found include the lack
Likert scale utilization, the overlap of confounding factors, multiple aspects of care impacting
the patient’s tolerance level during the time of insertion, and the nurse’s comment being the only
subjective data regarding tolerance for this set. There was a total of five comments from nurses
upon insertion stating the patient tolerating the procedure well. All of these occurrences
incorporated a topical analgesic into the IV insertion procedure. Due to these multiple
limitations, the efficacy of topical analgesics could have been impacted during this time.
Pain in the pediatric population during IV insertion has been proven to be preventable.
Preventing pain during the placement of an IV on the pediatric IPS unit significantly impacts the
patient, the patient’s family or caregivers, the nursing staff, and the provider. Preventing pain

DECREASING PREVENTABLE PAIN IN PEDIATRIC PATIENTS

48

with the utilization of PPIs is significant for the patient because it decreases the trauma
associated with the pain of an IV, which can promote long term health hygiene for the patient.
Parents, or other family members, are impacted by being actively involved in their child’s care
and also witnessing that PPIs are significant and recognized - even in a busy pediatric IPS.
Preventing pain during IV insertions is substantial to nursing staff because the patient can start
the procedure knowing the pain will be less, if not completely nonexistent. And overall, the
prevention of pain during IV insertion will be significant to the provider if the patient and family
are less anxious. Understanding the long and short-term significance for the entire team creates
the bigger picture for this DNP project. Preventing pain during IV insertions in the pediatric
realm of healthcare can create healthcare environments where the patient is less traumatized and
anxious, the parents are caregivers are involved, and the nursing staff can start IVs without
complications related to the pain of the procedure.
Sustainability of continuing the use of PPIs in the form of topical analgesics during IV
insertion on the pediatric IPS unit after project implementation is over could be difficult to
obtain. However, if the data reveal topical analgesics to be effective for pain prevention during
IV insertion at this hospital, standardization of utilizing PPIs during IV insertion is the next step.
Standardizing PPIs will be sustained by changing the policies and procedures involved in starting
IVs on the pediatric IPS unit at this hospital. This could be a change in the standing order set to
include topical analgesics for every IV ordered by a provider. With this specific project,
sustaining the intervention will be advantageous for future patients, families, nurses, and
providers.
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DNP Outcomes
This project will incorporate scientific underpinnings for practice by changing nursing processes
resulting in a positive change in the patient’s health status. It will incorporate organizational and
systems leadership for quality improvement and systems thinking by creating and evaluating a
process of care delivery to meet current and future needs of the pediatric population on the
pediatric IPS unit. This project will include clinical scholarship and analytical methods for EBP
by utilizing critically appraised research within the project and creating a baseline of change for
pain prevention interventions. This project will incorporate information systems/technology,
along with patient care technology, for the improvement of healthcare by utilizing patient
satisfaction surveys via online surveys and incorporating that into the implementation and
evaluation portions of this project. Health care policy for advocacy in health care will be seen in
this project by understanding previous experiences of pain and IV insertions from FTAC
members and their experiences. These interactions will advocate for a change in the policy
regarding PPIs and IV insertion. Interprofessional collaboration for improving patient outcomes
will be seen throughout this project as the stakeholders are composed of a multidisciplinary
team. This project will incorporate preventing population health issues by promoting health
hygiene at a young age starting with decreasing preventable pain during IV insertions. Lastly,
this project will incorporate advanced nursing practice by the overall design, implementation,
and evaluation of an intervention based on evidence-based nursing science.
Dissemination
The most important part of any evidence-based project is the dissemination of process,
findings, and overall implications of the project. For this DNP project, dissemination will be
focused primarily at a facility, community, and national level. Creating a PowerPoint
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presentation exemplifying the findings, lessons learned, and encouraging a Likert scale to be
placed back into the required charting will allow for further projects to take place at this facility.
Creating a time to present to the stakeholders regarding the results and what can be improved as
a whole will be imperative for such dissemination. Compiling and submitting a manuscript for
publishing amongst a peer-reviewed journal within one year of final defense is also a
dissemination option that will reach far more people to help progress pediatric healthcare. This
plan for dissemination will allow the progress and limitations found during this project to be
built upon for future projects by future scholars.
Conclusion
Working in the realm of healthcare is followed with many responsibilities. Working in
the pediatric realm of healthcare is accompanied with many more responsibilities. Creating a
patient and family centered environment is the evidence-based future of the pediatric realm.
Understanding the preventative pain and the duties that manifest from such education is
imperative to creating advancement and change. Pain prevention interventions are significant in
the overall healthcare of children and the way the view healthcare as they transition into
adulthood. Topical analgesics during pediatric IV insertions have been proven to be effective.
This project revealed topical analgesics are being utilized for IV insertions on the pediatric IPS
unit, but the percentage of utilization is fairly low. Standardizing topical analgesics for pain
prevention interventions prior to IV insertions should still be considered a priority.
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Appendix A
Johns Hopkins Nursing Evidence-Based Practice Research Appraisal Tool
Johns Hopkins Nursing Evidence-Based Practice Research Evidence Appraisal Tool
Evidence level and quality rating:
Article title:

Number:

Author(s):

Publication date:

Journal:

Setting:

Sample
(composition and size):

Does this evidence address my EBP question?

❑ Yes

❑No
Do not proceed with appraisal of this evidence.

Is this study:
■■

QuaNtitative (collection, analysis, and reporting of numerical data)

Measurable data (how many; how much; or how often) used to formulate facts, uncover patterns in research, and
generalize results from a larger sample population; provides observed effects of a
program, problem, or condition, measured precisely, rather than through researcher interpretation of data. Common
methods are surveys, face-to-face structured interviews, observations, and reviews of records or documents. Statistical tests
are used in data analysis.
Go to Section I: QuaNtitative
■■

QuaLitative (collection, analysis, and reporting of narrative data)

Rich narrative documents are used for uncovering themes; describes a problem or condition from the point of view of those
experiencing it. Common methods are focus groups, individual interviews (unstructured or semistructured), and
participation/observations. Sample sizes are small and are determined when data saturation is achieved. Data saturation
is reached when the researcher identifies that no new themes emerge and redundancy is occurring. Synthesis is used
in data analysis. Often a starting point for studies when little research exists; may use results to design empirical studies.
The researcher describes, analyzes, and interprets reports, descriptions, and observations from participants.

Go to Section II: QuaLitative
■■

Mixed methods (results reported both numerically and narratively)

Both quaNtitative and quaLitative methods are used in the study design. Using both approaches, in combination, provides
a better understanding of research problems than using either approach alone. Sample sizes vary based on methods used.
Data collection involves collecting and analyzing
both quaNtitative and quaLitative data in a single study or series of studies. Interpretation is continual and can influence
stages in the research process.
Go to Section I for QuaNtitative components and Section II for QuaLitative components
© The Johns Hopkins Hospital/ The Johns Hopkins University
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Johns Hopkins Nursing Evidence-Based Practice Research Evidence Appraisal Tool

Section I: QuaNtitative
Level of Evidence (Study Design)
❑ Yes

A. Is this a report of a single research study?

❑No
Go to B.

1. Was there manipulation of an independent
variable?

❑ Yes

❑No

2. Was there a control group?

❑ Yes

❑No

3. Were study participants randomly assigned to the
intervention and control groups?

❑ Yes

❑No

If Yes to questions 1, 2, and 3, this is a randomized
controlled trial (RCT) or experimental study.

❑ LEVEL I

If Yes to questions 1 and 2 and No to question 3, or Yes
to question 1 and No to questions 2 and 3, this is quasiexperimental (some degree of investigator control,
some manipulation of an independent variable, lacks
random assignment to groups, and may have a control
group).

❑ LEVEL II

If No to questions 1, 2, and 3, this is nonexperimental (no
manipulation of independent variable; can be
descriptive, comparative, or correlational; often uses
secondary data).

❑ LEVEL III

Study Findings That Help Answer the EBP Question

Complete the Appraisal of QuaNtitative Research Studies section.
© The Johns Hopkins Hospital/ The Johns Hopkins University

Page 2

DECREASING PREVENTABLE PAIN IN PEDIATRIC PATIENTS

55

Johns Hopkins Nursing Evidence-Based Practice Research Evidence Appraisal Tool

B. Is this a summary of multiple sources of research
evidence?
1. Does it employ a comprehensive search
strategy and rigorous appraisal method?

❑ Yes
Continue

❑ No

❑ Yes

❑ No

Go to Appendix F

Go to Appendix F

If this study includes research,
nonresearch, and experiential evidence, it
is an integrative review. See Appendix F.

2. For systematic reviews and systematic
reviews with meta-analysis (see
descriptions below):
a. Are all studies included RCTs?

❑ Level I

b. Are the studies a combination of RCTs
and quasi-experimental, or quasiexperimental only?

❑ Level II

c. Are the studies a combination of
RCTs, quasi-experimental, and
nonexperimental, or nonexperimental only?

❑ Level III

A systematic review employs a search strategy and
a rigorous appraisal method, but does not generate
an effect size.
A meta-analysis, or systematic review with
meta-analysis, combines and analyzes results
from studies to generate a new statistic: the effect
size.
Study Findings That Help Answer the EBP Question

Complete the Appraisal of Systematic Review (With or Without a Meta-Analysis) section.

© The Johns Hopkins Hospital/ The Johns Hopkins University
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Johns Hopkins Nursing Evidence-Based Practice Research Evidence Appraisal Tool

Appraisal of QuaNtitative Research Studies
Does the researcher identify what is known and not known about the
problem and how the study will address any gaps in knowledge?

❑ Yes

❑No

Was the purpose of the study clearly presented?

❑ Yes

❑No

Was the literature review current (most sources within the past five years
or a seminal study)?

❑ Yes

❑No

Was sample size sufficient based on study design and rationale?

❑ Yes

❑No

Were the characteristics and/or demographics similar in both the control
and intervention groups?

❑ Yes

❑No

❑ N/A

■■

If multiple settings were used, were the settings similar?

❑ Yes

❑No

❑ N/A

■■

Were all groups equally treated except for the intervention group(s)?

❑ Yes

❑No

❑ N/A

Are data collection methods described clearly?

❑ Yes

❑No

Were the instruments reliable (Cronbach’s  [alpha] > 0.70)?

❑ Yes

❑No

❑ N/A

Was instrument validity discussed?

❑ Yes

❑No

❑ N/A

If surveys or questionnaires were used, was the response rate > 25%?

❑ Yes

❑No

❑ N/A

Were the results presented clearly?

❑ Yes

❑No

If tables were presented, was the narrative consistent with the table
content?

❑ Yes

❑No

Were study limitations identified and addressed?

❑ Yes

❑No

Were conclusions based on results?

❑ Yes

❑No

❑ Yes

❑No

If there is a control group:
■■

❑ N/A

Go to Quality Rating for QuaNtitative Studies section
Appraisal of Systematic Review (With or Without Meta-Analysis)
Were the variables of interest clearly identified?
Was the search comprehensive and reproducible?
■■

Key search terms stated

❑ Yes

❑No

■■

Multiple databases searched and identified

❑ Yes

❑No

■■

Inclusion and exclusion criteria stated

❑ Yes

❑No

❑ Yes

❑No

Was there a flow diagram that included the number of studies
eliminated at each level of review?
© The Johns Hopkins Hospital/ The Johns Hopkins University
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Johns Hopkins Nursing Evidence-Based Practice Research Evidence Appraisal Tool

Were details of included studies presented (design, sample, methods, results,
outcomes, strengths, and limitations?

❑ Yes

❑No

Were methods for appraising the strength of evidence (level and quality)
described?

❑ Yes

❑No

Were conclusions based on results?

❑ Yes

❑No

Results were interpreted.

❑ Yes

❑No

Conclusions flowed logically from the interpretation and systematic review
question.

❑ Yes

❑No

❑ Yes

❑No

■■

■■

Did the systematic review include a section addressing limitations and
how they were addressed?
Quality Rating for QuaNtitative Studies
Complete quality rating for quaNtitative studies section.
Circle the appropriate quality rating below

A High quality: Consistent, generalizable results; sufficient sample size for the study design; adequate control; definitive conclusions;
consistent recommendations based on comprehensive literature review that includes thorough reference to scientific evidence.
B Good quality: Reasonably consistent results; sufficient sample size for the study design; some control, and fairly definitive
conclusions; reasonably consistent recommendations based on fairly comprehensive literature review that includes some
reference to scientific evidence.
C Low quality or major flaws: Little evidence with inconsistent results; insufficient sample size for the study design; conclusions
cannot be drawn.

Section II: QuaLitative
Level of Evidence (Study Design)
A. Is this a report of a single quaLitative research study?

❑ Yes

❑No

Level
III

Go to Section
II. B

Study Findings That Help Answer the EBP Question

Complete the Appraisal of Single QuaLitative Research Study section.
© The Johns Hopkins Hospital/ The Johns Hopkins University
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Johns Hopkins Nursing Evidence-Based Practice Research Evidence Appraisal Tool

Appraisal of a Single QuaLitative Research Study
Was there a clearly identifiable and articulated:
■■

Purpose?

❑ Yes

❑No

■■

Research question?

❑ Yes

❑No

■■

Justification for method(s) used?

❑ Yes

❑No

■■

Phenomenon that is the focus of the research?

❑ Yes

❑No

Were study sample participants representative?

❑ Yes

❑No

Did they have knowledge of or experience with the research area?

❑ Yes

❑No

Were participant characteristics described?

❑ Yes

❑No

Was sampling adequate, as evidenced by achieving saturation of data?

❑ Yes

❑No

❑ Yes

❑No

❑ Yes

❑No

Do findings support the narrative data (quotes)?

❑ Yes

❑No

Do findings flow from research question to data collected to analysis
undertaken?

❑ Yes

❑No

Are conclusions clearly explained?

❑ Yes

❑No

❑ Yes

❑ No Go to
Appendix F.

Data analysis:
Was a verification process used in every step by checking and
confirming with participants the trustworthiness of analysis and
interpretation?

■■

Was there a description of how data were analyzed (i.e., method), by computer
or manually?

■■

Go to Quality Rating for QuaLitative Studies section.
B. For summaries of multiple quaLitative research studies (meta-synthesis), was a
comprehensive search strategy and rigorous appraisal method used?

Level III

Study Findings That Help Answer the EBP Question

Complete the Appraisal of Meta-Synthesis Studies section.

© The Johns Hopkins Hospital/ The Johns Hopkins University
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Johns Hopkins Nursing Evidence-Based Practice Research Evidence Appraisal Tool

Appraisal of Meta-Synthesis Studies
Were the search strategy and criteria for selecting primary studies clearly defined?

❑ Yes

❑No

Were findings appropriate and convincing?

❑Yes

❑No

Was a description of methods used to:
■■

Compare findings from each study?

❑Yes

❑No

■■

Interpret data?

❑Yes

❑No

Did synthesis reflect:
■■

New insights?

❑Yes

❑No

■■

Discovery of essential features of phenomena?

❑Yes

❑No

■■

A fuller understanding of the phenomena?

❑Yes

❑No

❑Yes

❑No

Was sufficient data presented to support the interpretations?
Complete Quality Rating for QuaLtitative Studies section.
Quality Rating for QuaLitative Studies

Circle the appropriate quality rating below
No commonly agreed-on principles exist for judging the quality of quaLitative studies. It is a subjective process based on the
extent to which study data contributes to synthesis and how much information is known about the researchers’ efforts to meet the
appraisal criteria.
For meta-synthesis, there is preliminary agreement that quality assessments should be made before synthesis to screen out poor-quality studies1.

A/B High/Good quality is used for single studies and meta-syntheses)2.

The report discusses efforts to enhance or evaluate the quality of the data and the overall
inquiry in sufficient detail; and it describes the specific techniques used to enhance the
quality of the inquiry. Evidence of some or all of the following is found in the report:
Transparency: Describes how information was documented to justify decisions, how data were reviewed by others, and how
themes and categories were formulated.

■■

■■

Diligence: Reads and rereads data to check interpretations; seeks opportunity to find multiple sources to corroborate evidence.

■■

Verification: The process of checking, confirming, and ensuring methodologic coherence.

Self-reflection and self-scrutiny: Being continuously aware of how a researcher’s experiences, background, or
prejudices might shape and bias analysis and interpretations.

■■

■■

Participant-driven inquiry: Participants shape the scope and breadth of questions; analysis and
interpretation give voice to those who participated.
■■

C

Insightful interpretation: Data and knowledge are linked in meaningful ways to relevant literature.

Lower-quality studies contribute little to the overall review of findings and have few, if
any, of the features listed for High/Good quality.
© The Johns Hopkins Hospital/ The Johns Hopkins University
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Johns Hopkins Nursing Evidence-Based Practice Research Evidence Appraisal Tool

Section III: Mixed Methods
Level of Evidence (Study Design)
You will need to appraise both the quaNtitative and quaLitative parts of the
study independently, before appraising the study in its entirety.
1. Evaluate the quaNtitative portion of the study using Section I. Insert here the
level of evidence and overall quality for this part:

Level

Quality

2. Evaluate the quaLitative part of the study using Section II. Insert here the level
of evidence and overall quality for this part:

Level

Quality

3. To determine the level of evidence, circle the appropriate study design:
(a) Explanatory sequential designs collect quaNtitative data first, followed
by the quaLitative data; and their purpose is to explain quaNtitative
results using quaLitative findings. The level is determined based on the
level of the quaNtitative part.
(b) Exploratory sequential designs collect quaLitative data first, followed
by the quaNtitative data; and their purpose is to explain quaLitative
findings using the quaNtitative results. The level is determined based
on the level of the quaLitative part, and it is always Level III.
(c) Convergent parallel designs collect the quaLitative and quaNtitative
data concurrently for the purpose of providing a more complete
understanding of a phenomenon by merging both datasets. These
designs are Level III.
(d) Multiphasic designs collect quaLitative and quaNtitative data over more
than one phase, with each phase informing the next phase. These
designs are Level III.

Study Findings That Help Answer the EBP Question

Use the Appraisal of Mixed Methods Studies section.
© The Johns Hopkins Hospital/ The Johns Hopkins University
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Johns Hopkins Nursing Evidence-Based Practice Research Evidence Appraisal Tool

Appraisal of Mixed Methods Studies 3
Was the mixed-methods research design relevant to address the
quaNtitative and quaLitative research questions (or objectives)?

❑ Yes

❑No

❑ N/A

Was the research design relevant to address the quaNtitative and
quaLitative aspects of the mixed-methods question (or objective)?

❑ Yes

❑No

❑ N/A

For convergent parallel designs, was the integration of quaNtitative and
quaLitative data (or results) relevant to address the research question or
objective?

❑ Yes

❑ No

❑ N/A

For convergent parallel designs, were the limitations associated with the
integration (for example, the divergence of quaLitative and quaNtitative
data or results) sufficiently addressed?

❑ Yes

❑ No

❑ N/A

Quality Rating for Mixed-Methods Studies
Circle the appropriate quality rating below
A High quality: Contains high-quality quaNtitative and quaLitative study components; highly relevant study design; relevant
integration of data or results; and careful consideration of the limitations of the chosen approach.
B Good quality: Contains good-quality quaNtitative and quaLitative study components; relevant study design; moderately relevant
integration of data or results; and some discussion of limitations of integration.
C Low quality or major flaws: Contains low quality quaNtitative and quaLitative study components; study design not relevant to
research questions or objectives; poorly integrated data or results; and no consideration of limits of integration.
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